1. Home
  2. MBIO vs SPHL Comparison

MBIO vs SPHL Comparison

Compare MBIO & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBIO

Mustang Bio Inc.

N/A

Current Price

$0.89

Market Cap

7.0M

Sector

Health Care

ML Signal

N/A

Logo Springview Holdings Ltd Class A Ordinary Shares

SPHL

Springview Holdings Ltd Class A Ordinary Shares

N/A

Current Price

$3.12

Market Cap

7.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
MBIO
SPHL
Founded
2015
2002
Country
United States
Singapore
Employees
N/A
71
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.0M
7.3M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
MBIO
SPHL
Price
$0.89
$3.12
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
44.0K
30.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$0.35
52 Week High
$7.00
$25.11

Technical Indicators

Market Signals
Indicator
MBIO
SPHL
Relative Strength Index (RSI) 40.78 45.64
Support Level $0.53 $0.41
Resistance Level $1.10 $5.38
Average True Range (ATR) 0.07 0.36
MACD -0.00 -0.01
Stochastic Oscillator 14.20 40.55

Price Performance

Historical Comparison
MBIO
SPHL

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment - in the development of construction projects. It derives maximum revenue from its Residential Customers.

Share on Social Networks: